RVAC Medicines Pte.
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- $140M
Investors
- 4
About RVAC Medicines Pte.
Based in Singapore, and founded in 2021 by its CEO Sean Fu, and CSO Jason Zhang, RVAC Medicines Pte. Ltd. operates as a messenger (mRNA) ribonucleic acid platform company. In April 2022, RVAC Medicines Pte. Ltd. RVAC Medicines provides GMP manufacturing capabilities; MSAT infrastructure for process scale-up and tech transfer; develops single and multi-mRNA/DNA products, etc.
Who invested in RVAC Medicines Pte.
4 investors across 1 round
See all investors in RVAC Medicines Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 26, 2022
Amount
$140M
Investors
Questions about RVAC Medicines Pte.
Who invested in RVAC Medicines Pte.?
RVAC Medicines Pte. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RVAC Medicines Pte. raised?
RVAC Medicines Pte. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RVAC Medicines Pte. last raise money?
RVAC Medicines Pte.'s most recent round on record is a Series B, in Apr 2022.
What does RVAC Medicines Pte. do?
Based in Singapore, and founded in 2021 by its CEO Sean Fu, and CSO Jason Zhang, RVAC Medicines Pte.
Where is RVAC Medicines Pte. headquartered?
RVAC Medicines Pte. is headquartered in Singapore.
Which VCs invest in companies like RVAC Medicines Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at RVAC Medicines Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like RVAC Medicines Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.